New Generation of Products

Enriched Cancer Stem Cells or CancerStemCells™

• BioMedicure's enriched cancer stem cells are tumorigenic, heterogeneous and randomly mutating living cancer cells resulted from propreitary processes.
• Enriched cancer stem cells can grow "solid tumor" in vitro without the aid of matrix gel or the supplement of growth factors.
• Enriched cancer stem cells can survive under extreme conditions such as an environment where nutrients are exhausted or partially depleted.
• Enriched CancerStemCell™ products for mouse (Melanoma, CSC-016 view; Liver hepatoma, CSC-026 view; Renal adenocarcinoma, CSC-142 view; Rectum polyploid carcinoma, CSC-223 view; Mammary gland tumor, CSC-539 view; Colon carcinoma, CSC-638 view; Lewis lung carcinoma, CSC-642 view), rat (Testis tumor, CSC-043 view; Gliosarcoma, CSC-200 view; Malignant prostate carcinoma, CSC-376 view; Urinary bladder tumor, CSC-655 view; Osteosarcoma, CSC-661 view; Adenocarcinoma, CSC-677 view; Mammary gland adenocarcinoma, CSC-743 view; Neuroblastoma, CSC-754 view), chicken (Hepatocellular carcinoma, CSC-118 view), guinea pig (Colorectal adenocarcinoma, CSC-242 view), hamster (Melanoma, CSC-049 view), dog (Osteosarcoma, CSC-130 view) and human (Cervical adenocarcinoma, CSC-002 view; Glioblastoma/astrocytoma, CSC-014 view; Breast adenocarcinoma, CSC-022 view; Burkitt's lymphoma, CSC-086 view; Lung epidermoid carcinoma, CSC-199 view; Colon adenocarcinoma, CSC-221 view; Pancreatic carcinoma, CSC-420 view; Kidney rhabdoid tumor, CSC-441 view; Colorectal adenocarcinom CSC-480 view) have been developed.

Anti-cancer Agent Tumorase™

• BioMedicure's Tumorase™ products (T-101 view, T-105 view, T-110 view) are biochemotherapeutic agents that can quickly and effectively destroy the solid-structure of a solid tumor and kill cancer cells, including cancer stem cells, within an hour.
• BioMedicure uses Tumorase™ to make its propreitary CancerVaccine products and has developed a Tumorase™ whole Cell Cancer Vaccine Kit (TK-110 view) to share with cancer researchers.

Cancer vaccine products CancerVaccine™

• BioMedicure's CancerVaccine™ are true cancer vaccines that not only can be used for cancer prevention but also can be employed for cancer treatment or immunotherapy.
• Each Cancer Vaccine™ product is made out of in vitro "solid tumors" grown by corresponding enriched cancer stem cells or CancerStemCell™ treated with Tumorase™.
• BioMedicure's CancerVaccine™ giant liposomes induces the most potent immune responses against cancer cells, including cancer stem cells specifically.
• One group of the immune response components are cancer cell specific polyclonal antibodies or AntiCancerBody™, which is currently under development and will be shared with cancer researchers soon.
• CancerVaccine™ products for mouse (Melanoma, CV-016-1 view; Liver hepatoma, CV-026-1 view; Renal adenocarcinoma, CV-142-1 view; Rectum polyploid carcinoma, CV-223-1 view; Mammary gland tumor, CV-539-1 view; Colon carcinoma, CV-638-1 view; Lewis lung carcinoma, CV-642-1 view), rat (Testis tumor, CV-043-1 view; Gliosarcoma, CV-200-1 view; Malignant prostate carcinoma, CV-376-1 view; Urinary bladder tumor, CV-655-1 view; Osteosarcoma, CV-661-1 view; Adenocarcinoma, CV-677-1 view; Mammary gland adenocarcinoma, CV-743-1 view; Neuroblastoma, CV-754-1 view), chicken (Hepatocellular carcinoma, CV-118-1 view), guinea pig (Colorectal adenocarcinoma, CV-242-1 view), hamster (Melanoma, CV-049-1 view), dog (Osteosarcoma, CV-130-1 view) and human (Cervical adenocarcinoma, CV-002-1 view; Glioblastoma/astrocytoma, CV-014-1 view; Breast adenocarcinoma, CV-022-1 view; Burkitt's lymphoma, CV-086-1 view; Lung epidermoid carcinoma, CV-199-1 view; Colon adenocarcinoma, CV-221-1 view; Pancreatic carcinoma, CV-420-1 view; Kidney rhabdoid tumor, CV-441-1 view; Colorectal adenocarcinoma, CV-480-1 view) have been developed.